CAS No.:12663-46-6
Name: Cyclochlorotine
Details Introduction
TOXICITY DATA with REFERENCE:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
guinea pig | LD50 | subcutaneous | 500mg/kg (500mg/kg) | VASCULAR: OTHER CHANGES LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES |
Journal of Toxicological Sciences. Vol. 2, Pg. 349, 1977. |
mouse | LD50 | intraperitoneal | 330ug/kg (0.33mg/kg) | Clinical Toxicology. Vol. 17, Pg. 45, 1980. | |
mouse | LD50 | intravenous | 335ug/kg (0.335mg/kg) | LIVER: "HEPATITIS, FIBROUS (CIRRHOSIS, POST-NECROTIC SCARRING)" | Food and Cosmetics Toxicology. Vol. 10, Pg. 193, 1972. |
mouse | LD50 | oral | 6550ug/kg (6.55mg/kg) | LIVER: "HEPATITIS (HEPATOCELLULAR NECROSIS), ZONAL" LIVER: "HEPATITIS, FIBROUS (CIRRHOSIS, POST-NECROTIC SCARRING)" LIVER: OTHER CHANGES |
Food and Cosmetics Toxicology. Vol. 10, Pg. 193, 1972. |
mouse | LD50 | subcutaneous | 475ug/kg (0.475mg/kg) | LIVER: OTHER CHANGES ENDOCRINE: HYPOGLYCEMIA ENDOCRINE: HYPERGLYCEMIA |
Food and Cosmetics Toxicology. Vol. 10, Pg. 193, 1972. |
rat | LD50 | oral | 5mg/kg (5mg/kg) | VASCULAR: OTHER CHANGES LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES |
Journal of Toxicological Sciences. Vol. 2, Pg. 349, 1977. |
rat | LD50 | subcutaneous | 400ug/kg (0.4mg/kg) | VASCULAR: OTHER CHANGES LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES |
Journal of Toxicological Sciences. Vol. 2, Pg. 349, 1977. |
rat | LDLo | intraperitoneal | 50mg/kg (50mg/kg) | Applied and Environmental Microbiology. Vol. 35, Pg. 1074, 1978. |
Consensus Reports:
IARC Cancer Review: Group 3 IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 7 , 1987,p. 56.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Limited Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 10 , 1976,p. 139.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) .
SAFETY PROFILE:
A deadly poison by ingestion, subcutaneous, intraperitoneal, and intravenous routes. Questionable carcinogen with experimental tumorigenic data. When heated to decomposition it emits very toxic fumes of Cl− and NOx.
Standards and Recommendations:
Analytical Methods:
Related Searches
Other Product
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (4S,6R)-6-{2-[(2-hydroxy-ethyl)-(4-methoxy-benzenesulfonyl)-amino]-ethoxy}-4-isopropyl-5,6-dihydro-4H-pyran-2-carboxylic acid allyl ester
- [1,4'-Bipiperidine]-1'-carboxylic acid, 4-(1H-indol-7-yl)-, ethyl ester
- 1,3,5-Tris(4-acetamidophenyl)penta-1,5-dione
- 1,5-Bis(3-aminophenyl)-3-(4-N,N-di-methylaminophenyl)penta-1,5-dione
- 1,5-Bis(4-acetamidophenyl)-3-phenylpenta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-(4-acetamido-phenyl)penta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-phenylpenta-1,5-dione